TNS Issues New Reports on Stocks with Potential Near Term Catalysts and a Feature Green Energy NASDAQ Report
April 12 2022 - 8:30AM
InvestorsHub NewsWire
TNS Issues New Reports on Stocks
with Potential Near Term Catalysts and a Feature Green Energy
NASDAQ Report
New York, NY -- April 12, 2022 -- InvestorsHub NewsWire -- via
Traders News Source
-- Traders News Source, a leading independent equity
research and corporate access firm focused on small cap growth
companies issues new research.
Emerging EV producer Mullen Automotive, Inc. (NASDAQ:
MULN) is trying to make a comeback after losing nearly
half its value this year. That effort was aided by an apparent
short squeeze that saw the company shares quadruple over a 2-week
period last month. Short interest in Mullen shares continues to
hover around 25% of the available shares and some investors are
wondering if another short squeeze may be around the corner. Last
week, Sunshine Biopharma, Inc. (NASDAQ:
SBFM) announced that two of its newly designed mRNA
molecules are effective at destroying cancer cells grown in culture
and the company shares gained significantly on the news. Dr. Steve
Slilaty, CEO of Sunshine Biopharma said, “The potential use of mRNA
to treat cancer opens the door to many possibilities for patients
including convenience, reduced toxicity and enhanced efficacy.”
Will a short squeeze happen at MULN near-term? Is SBFM on the verge
of an oncology breakthrough? READ MORE
Copy and paste to browser may be required- https://tradersnewssource.com/new-reports-feature-report/
Northwest Biotherapeutics, Inc. (OTCQB:
NWBO) a biotechnology company developing DCVax®
personalized immune therapies for solid tumor cancers, after
spending years in preparation, is now operating under the UK
Medicines and Healthcare Products Regulatory Agency (MHRA) license
for manufacture of GMP (clinical grade) cell therapy products. The
company is in production of its first dendritic cell cancer vaccine
at its new facility. The giant home mortgage servicing company,
Mr. Cooper Group Inc. (NASDAQ:
COOP) recently announced an agreement with Sagent
M&C, LLC, d/b/a Sagent Lending Technologies. This agreement
will leverage Mr. Cooper’s mortgage servicing depth and Sagent’s
software innovation speed to create the industry’s first
cloud-native, homeowner-first servicing platform.
Will DCVax be a successful product for NWBO? How exactly will COOP
benefit from the new Sagent agreement? READ MORE
Copy and paste to browser may be required – https://tradersnewssource.com/new-reports-feature-report/
Disclosure
Traders News Source LLC (TNS)
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
small and micro-cap equity markets. TNS has two distinct and
independent departments. One department produces non-sponsored
analyst certified content generally in the form of press releases,
articles and reports covering equities listed on NYSE, NASDAQ, and
OTC exchanges. The other produces sponsored content (in most cases
not reviewed by a registered analyst), which typically consists of
compensated investment newsletters, articles and reports covering
listed stocks and micro-caps. Such sponsored content is outside the
scope of procedures detailed below.
PRESS RELEASE PROCEDURES
The non-sponsored content contained
herein has been prepared by a writer (the "Author") and is fact
checked and reviewed by a third-party research service company (the
"Reviewer") represented by a chartered financial analyst, for
further information on analyst credentials, please email
editor@tradersnewssource.com. TNS LLC provides necessary guidance
in preparing the document templates. The Reviewer has reviewed and
revised the content, as necessary, based on publicly available
information which is believed to be reliable. Content is
researched, written, and reviewed on a reasonable-effort basis. The
Reviewer has not performed any independent investigations or
forensic audits to validate the information herein. The Reviewer
has only independently reviewed the information provided by the
Author per the procedures outlined by TNS. TNS is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents, or
reports. Unless otherwise noted, any content outside of this
document has no association with the Author or the Reviewer in any
way.
NO WARRANTY
TNS, the Author, and the Reviewer are
not responsible for any error which may be occasioned at the time
of printing of this document or any error, mistake, or shortcoming.
No liability is accepted whatsoever for any direct, indirect, or
consequential loss arising from the use of this document. TNS, the
Author, and the Reviewer expressly disclaim any fiduciary
responsibility or liability for any consequences, financial or
otherwise arising from any reliance placed on the information in
this document. Additionally, TNS, the Author, and the Reviewer do
not (1) guarantee the accuracy, timeliness, completeness, or
correct sequencing of the information, or (2) warrant any results
from use of the information. The included information is subject to
change without notice.
NOT AN OFFERING
This document is not intended as an
offering, recommendation, or a solicitation of an offer to buy or
sell the securities mentioned or discussed and is to be used for
informational purposes only. Please read all associated disclosures
and disclaimers in full before investing. Neither TNS nor any party
affiliated with us is a registered investment adviser or
broker-dealer with any agency or in any jurisdiction whatsoever. To
download our report(s), read our disclosures, or for more
information, visit http://www.tradersnewssource.com.
For any questions, inquiries, or
comments reach out to us directly. If you're a company we are
covering and wish to no longer be featured on our coverage list,
contact us via email at: editor@tradersnewssource.com
CFA® and Chartered Financial Analyst®
are registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News
Source
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Dec 2024 to Jan 2025
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Jan 2024 to Jan 2025